Optibiotix Health Share Discussion Threads

[john henry] 13/11/2016 16:57

If OPTI was dual listed, the minimum share price would be double the present price

[john henry] 12/11/2016 21:26

Parob I think OPTI would do very very well with a Nasdaq listing. Look at GWP. US investors appetite for biotech is a lot strong than in the UK where in general investors a simply not interested.

[parob] 12/11/2016 08:00

PITCH YOUR MICROBES!

An opportunity for OPTI to pitch to Janssen/J&J at the European Microbiome Congress this month (if they're not talking to them already)?

They meet one of the requirements to pitch:

'A biotech company at the pre-revenue or post-revenue stage, looking for investment, partnerships and advice.'

[judijudi] 11/11/2016 21:51

Good post risky

[judijudi] 11/11/2016 16:02

We need some good news to bring in buyers. 100k shares traded is pitiful really

[f3rdinand] 11/11/2016 15:56

If the launch is low-key in only one or two small stores - like gofigure- then yes, I doubt there'll be much (initial) response in share price If however there are a multitude of large retailers getting involved then that'll be a totally different story!This won't just be 'any other supplement' it will have hard science backing it up (in well respected journals) and I'd imagine large chemists will be clambering to stock a product that slashes cholesterol so dramatically! I'm pretty shocked that gofigure is in profit so early on... if we can get into big stores internationally with it, then that alone will cause a massive uplift on SP!I also believe skinbiotix will be huge and am guessing J&J will be involved in the demerger in some way! Interesting next few months for sure! I'm still expecting some major news at any time that will propel us northwards!

[neftanikoff] 11/11/2016 15:51

should be another 1/2 rns's November (this year)

[mazzstar] 11/11/2016 15:25

Bokke, by solo I mean we are not partnering with a MN yet. And they are hardly suppositions. Have you read the comments earlier today by a few posters who discussed why no RNS was required for the launch of Gofigure and why in the RNS on 26/10 there was no mention of the partner? I don't wholly buy the NDA angle as it's been over 18 months of 'discussions' and I think perhaps that is more of a tactic by Opti to keep everything under wraps including how they plan to launch their own product with a minnow partner. But we shall see what happens in April when Gofigure 2.0 version comes to market and the share price couldn't care less. MN deal is required here, not a startup.

[1bokke] 11/11/2016 15:08

Mazz, how does it appear that we are going solo? All we have is the rns which does not indicate in either direction, you appear to have arrived at your conclusion based on our suppositions on this thread!! I have emailed to see if any more info could be given and I have had a response to say for reasons of confidentiality no more can be released at this time( not unexpected if we are under NDA) I get the impression that Opti are as frustrated as we are that news can't be released yet.. As for Go Figure, Iceland(the country) is confirmed as a new market and I understand more markets will open as brand recognition increases. IMHO things are progressing well and if you are planning to be a long term holder then all is looking good..

[fozdad] 11/11/2016 14:28

Mazz, with luck, you'll be able to make your investment of choice in the next few months!

[mazzstar] 11/11/2016 14:03

How come we were told for months by SOH that discussions with the MN are ongoing and yet it would appear Opti is going solo in April? I agree with someuwin that it's still all positive if we indeed go down the route of something similar to Gofigure for the cholesterol product but I do feel misled by TW and SOH into thinking that this was big pharma when I suspect it will be more like a supplement pill in niche health food stores like Wholefoods, Revital and possibly Holland & Barrett. Anyway, I don't really need to repeat myself but I think I know what is going on here. That said, the reason I am so heavily invested here is because of Skinbiotix and I would've sold a year ago but this is a very exciting field and I think it will be massive one day. In hindsight, I would've preferred to invest solely in Skinbiotix as the prebiotic/supplement market is saturated now and I could not care less about shakes and bars. Moreover, Skinbiotix would appear as our most lucrative opportunity to venture into pharma as this is after all a biotech share or so I thought. I'm long and strong for Johnson & Johnson not this Gofigure shyte (sorry but that is my opinion on it).

[judijudi] 11/11/2016 13:08

Best filter me if my genuine observations iritate you guys
Quite simple really

[judijudi] 11/11/2016 13:03

Primal read my last sentence
Stay cool, hold your shares and with luck the science will do the talking for the share price

and even my post below

10 Nov '16 - 09:39 - 17268 of 17320 1 0 Edit
I'm pretty sanguine aboout it all

Or "I'm cool with my investment"

Is that negative????

I'm happy to be holding. Extremely happy. But I don't go through life with Rose Tinted specs on!!!

[kipper1960] 11/11/2016 12:58

Judi, you seem to really have a problem with SOH and his interviews. Do you honestly believe that if he spent less time doing interviews he would get more/better/quicker deals done? That's very naive IMHO.
In my view, PR companies are there to organise PR activities and it IS the CEO's job to do the delivery.

[primal123] 11/11/2016 12:58

I can't be bothered with you Judi, there is a reason why a lot have had the same issues with you, you're negative. End of.

[judijudi] 11/11/2016 12:54

If you read my posts (slowly this time)
I don't think I am moaning as you put it
I'm observing and slightly criticising
Big difference to moaning
Check the OED

[primal123] 11/11/2016 12:49

People like to hear from the CEO himself, if he didn't say anything you would be moaning at that too. There has been a lot of positives this year and deals made. Need patience.

[judijudi] 11/11/2016 12:41

Primal,
What are PR companies or PR employees for?

[primal123] 11/11/2016 12:37

Judi - he has to do interviews to promote the company. The deals will follow. People keep going back to that point about 4-5 deals by November but they could say that since the comment there has been a 1. JV with University of Manchester 2. JV with Royal DSM3. JV with GoFigureSo they could argue that there is 3 deals already. It's us as shareholders who want the big RNS which is understandable.

[judijudi] 11/11/2016 11:44

The fact that soh has so much "skin in the game" means Jack Shyte. Aim is littered with failed companies and those about to fail where every single one of these companies CEO and bod's had plenty of "skin in the game"
It means nothing
What is important is that the science works, not how many shares soh may or may not have!
I'm cool with my investment.
The only criticism I have of soh is to make deadlines and target dates and then fail to meet them. You think that these guys would learn that things rarely run on time and to plan.
The other minor gripe I have of him is he seems to be a bit of a self promoter and must love the sound of his own voice.
Get on with running the company, deal making and cut the interviews out!
Stay cool, hold your shares and with luck the science will do the talking for the share price

[spike_1] 11/11/2016 10:19

fozdad, many thanks for that 'update'. My memory is not as good as it was ... some days I have to wait 'till the post arrives to discover who I am ;0(

Best wishes - Mike

[maxwellsdemon] 11/11/2016 10:16

Sleep loss alters gut microbiota


Just 2 days of sleep loss may trigger changes in gut microbiota that are associated with poor metabolic health. This is the finding of a small study published in the journal Molecular Metabolism.

[someuwin] 11/11/2016 10:12

At the moment its still only an anticipated launch - still some work to do I imagine.

I'm sure once everything is confirmed they will give us all the details next spring.

Won't affect those who keep telling us they are going to sell out at the end of this year though!

"...the launch of a range of cardiovascular products to reduce LDL cholesterol, blood pressure, and cardiovascular risk, anticipated for the spring of 2017."